CuroVax

Changzhou, China · Founded 2011 · Privately Held (backing)

Manufacturer of human vaccine products and immunization technologies aims to advance global public health through innovative vaccine development. CuroVax is based in Changzhou, China and was founded in 2011. Its last reported valuation was $405 million in Jan 2024. It has raised $74.2 million.

Last reported valuation
$405.0M
Oct 2026
Priced at
—
Total raised
$74.2M
Last round
—

Who backs CuroVax?

18 investors
InvestorType
Qiming Venture PartnersVenture capital
Green Pine Capital PartnersVenture capital
Tailong VCOther
Hankang CapitalVenture capital
Beijing Jiurui Tiancheng TechnologyOther
AbogenBio—
Beijing Shine Asset—
BioTrack Capital—
Delonix Bioworks—
Guanyou Development Investment—
+ 8 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

CuroVax investors

18 investors are on record for CuroVax, including Qiming Venture Partners, Green Pine Capital Partners, Tailong VC and Hankang Capital.

Free account
More of CuroVax with a free account
  • ·The complete investor list: 18 names
  • ·Watch CuroVax: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 18 firms already write checks for companies like CuroVax. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View